InvestorsHub Logo
Followers 6
Posts 943
Boards Moderated 0
Alias Born 09/28/2012

Re: friendofthedevil post# 5183

Thursday, 03/02/2017 12:24:48 PM

Thursday, March 02, 2017 12:24:48 PM

Post# of 9388
I agree we are undervalued but I would think today's news must be part of the reason for today's move. Roche is up 6%.

"Some 70 percent of the drugmaker’s $6.8 billion in Herceptin revenue last year came from patients who might benefit from the combination tested in the trial, dubbed Affinity."
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent HALO News